Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by VITULLO NICOLE, Director. Officer active across 2 companies, notably Esperion Therapeutics, Inc.. In total, 5 disclosures have been published. History available since 27 May 2021. The latest transaction was disclosed on 15 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
5 of 5 declarations
Nicole Vitullo is a Director at Esperion Therapeutics, Inc. and Marinus Pharmaceuticals Inc. She plays a key role in overseeing the activities of these companies and guiding their strategy. Nicole leverages her expertise to contribute to strategic decision-making within the boards.